Calcium chloride, dextrose, anhydrous, magnesium chloride hexahydrate, phosphoric acid 85 percent, potassium chloride (Neolyte)
Calcium chloride, dextrose, anhydrous, magnesium chloride hexahydrate, phosphoric acid 85 percent, potassium chloride
Fresenius Kabi Manufacturing SA (Pty) Ltd
Registration
- Applicant
- Fresenius Kabi Manufacturing SA (Pty) Ltd
- Certificate holder
- Fresenius Kabi Manufacturing SA (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Neolyte EACH 200,0 ml SOLUTION CONTAINS CALCIUM CHLORIDE DIHYDRATE 73,4 mg DEXTROSE, ANHYDROUS 20,0 g MAGNESIUM CHLORIDE HEXAHYDRATE 20,4 mg PHOSPHORIC ACID 85 PERCENT 86,36 mg POTASSIUM CHLORIDE 224,0 mg SODIUM LACTATE S | 1 000 mlSolution for infusion | R0243R/24/243Approved 1 July 2021 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.